← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2016Last known activity
Dec 31, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT03567473Overall official - principal investigatorPhase 3Dec 31, 2018
- NCT02561117Lead sponsorPhase 4Jun 1, 2017
- NCT02876094Lead sponsorPhase 2Sep 1, 2016
Details
- Last known activity
- Dec 31, 2018